The liver adventures of bariatric endoscopy

Ivo Boškoski

doi:10.1055/a-2160-1581

Endoscopy, Inhaltsverzeichnis

Endoscopy 2023; 55(11): 1035-1036
DOI: 10.1055/a-2160-1581

Editorial

The liver adventures of bariatric endoscopy

Referring to AlKhatry M et al. p. 1028–1034

Ivo Boškoski

¹Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome Italy, Univerisità Cattolica del Sacro Cuore di Roma, Rome, Italy

References
1 Muhamad NA, Maamor NH, Leman FN. et al. The global prevalence of nonalcoholic fatty liver disease and its association with cancers: systematic review and meta-analysis. Interact J Med Res 2023; 12: e40653
2 Jastreboff AM, Aronne LJ, Ahmad NN. et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med 2022; 387: 205-216
3 Matteo MV, Bove V, Pontecorvi V. et al. Outcomes of endoscopic sleeve gastroplasty in the elder population. Obes Surg 2022; 32: 3390-3397
4 Alqahtani A, Elahmedi M, Alqahtani YA. et al. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: two-year outcomes of a new modality. Am J Gastroenterol 2019; 114: 1857-1862
5 Leung JC, Loong TC, Wei JL. et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 2017; 65: 54-64
6 Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L. et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 2015; 149: 367-378.e5
7 AlKhatry M, Rapaka B, Maselli DB. et al. Improvements in hepatic steatosis, obesity, and insulin-resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure. Endoscopy 2023; 55: 1028-1034